Want to join the conversation?
$AES updated its outlook for adjusted EPS growth through 2018. Although the net impact on 2016 adjusted EPS guidance is approx. $0.20, $AES believe that cost savings and another initiative will reduce the net decrease to about $0.06 per share by 2018, which keeps the guidance within the low end of previous 2018 expectations.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?